| Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes JD McKay, RJ Hung, Y Han, X Zong, R Carreras-Torres, DC Christiani, ... Nature genetics 49 (7), 1126-1132, 2017 | 627 | 2017 |
| Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress KD Graves, SM Arnold, CL Love, KL Kirsh, PG Moore, SD Passik Lung cancer 55 (2), 215-224, 2007 | 462 | 2007 |
| Human rRNA gene clusters are recombinational hotspots in cancer DM Stults, MW Killen, EP Williamson, JS Hourigan, HD Vargas, ... Cancer research 69 (23), 9096-9104, 2009 | 191 | 2009 |
| Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD (L)-1 … JD Schoenfeld, A Giobbie-Hurder, S Ranasinghe, KZ Kao, A Lako, J Tsuji, ... The Lancet Oncology 23 (2), 279-291, 2022 | 174 | 2022 |
| Diagnosis and management of brain metastases SM Arnold, RA Patchell Hematology/Oncology Clinics 15 (6), 1085-1108, 2001 | 152 | 2001 |
| Shared heritability and functional enrichment across six solid cancers X Jiang, HK Finucane, FR Schumacher, SL Schmit, JP Tyrer, Y Han, ... Nature communications 10 (1), 431, 2019 | 130 | 2019 |
| Causal relationships between body mass index, smoking and lung cancer: univariable and multivariable Mendelian randomization W Zhou, G Liu, RJ Hung, PC Haycock, MC Aldrich, AS Andrew, SM Arnold, ... International journal of cancer 148 (5), 1077-1086, 2021 | 124 | 2021 |
| One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer KM Luginbuhl, JL Schaal, B Umstead, EM Mastria, X Li, S Banskota, ... Nature biomedical engineering 1 (6), 0078, 2017 | 122 | 2017 |
| Elevated progesterone receptor membrane component 1/sigma‐2 receptor levels in lung tumors and plasma from lung cancer patients SUR Mir, ISA Ahmed, S Arnold, RJ Craven International Journal of Cancer 131 (2), E1-E9, 2012 | 121 | 2012 |
| Strong, steady and straight: UK consensus statement on physical activity and exercise for osteoporosis K Brooke-Wavell, DA Skelton, KL Barker, EM Clark, S De Biase, S Arnold, ... British journal of sports medicine 56 (15), 837-846, 2022 | 120 | 2022 |
| Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study J Feddock, SM Arnold, BJ Shelton, P Sinha, G Conrad, L Chen, J Rinehart, ... International Journal of Radiation Oncology* Biology* Physics 85 (5), 1325-1331, 2013 | 111 | 2013 |
| Obesity, metabolic factors and risk of different histological types of lung cancer: a Mendelian randomization study R Carreras-Torres, M Johansson, PC Haycock, KH Wade, CL Relton, ... PloS one 12 (6), e0177875, 2017 | 106 | 2017 |
| Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying NA Stocke, SA Meenach, SM Arnold, HM Mansour, JZ Hilt International journal of pharmaceutics 479 (2), 320-328, 2015 | 97 | 2015 |
| Exosomal lipids for classifying early and late stage non-small cell lung cancer TWM Fan, X Zhang, C Wang, Y Yang, WY Kang, S Arnold, RM Higashi, ... Analytica chimica acta 1037, 256-264, 2018 | 94 | 2018 |
| Is high vitamin B12 status a cause of lung cancer? A Fanidi, R Carreras‐Torres, TL Larose, JM Yuan, VL Stevens, ... International journal of cancer 145 (6), 1499-1503, 2019 | 91 | 2019 |
| Expression of p53, bcl-2, E-cadherin, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasis SM Arnold, AB Young, RK Munn, RA Patchell, N Nanayakkara, ... Clinical cancer research 5 (12), 4028-4033, 1999 | 88 | 1999 |
| Subacromial balloon spacer for irreparable rotator cuff tears of the shoulder (START: REACTS): a group-sequential, double-blind, multicentre randomised controlled trial A Metcalfe, H Parsons, N Parsons, J Brown, J Fox, EG Mannion, A Haque, ... The Lancet 399 (10339), 1954-1963, 2022 | 87 | 2022 |
| Clinical outcomes of molecular tumor boards: a systematic review KL Larson, B Huang, HL Weiss, P Hull, PM Westgate, RW Miller, ... JCO precision oncology 5, 1122-1132, 2021 | 82 | 2021 |
| Identification of susceptibility pathways for the role of chromosome 15q25. 1 in modifying lung cancer risk X Ji, Y Bossé, MT Landi, J Gui, X Xiao, D Qian, P Joubert, M Lamontagne, ... Nature Communications 9 (1), 3221, 2018 | 79 | 2018 |
| Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised … RS Herbst, MW Redman, ES Kim, TJ Semrad, L Bazhenova, G Masters, ... The Lancet Oncology 19 (1), 101-114, 2018 | 79 | 2018 |
